Market Overview:
The global medical isotopes market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nuclear therapy and rising incidence of cancer. Additionally, the growing demand for radioisotopes in equipment radioactive source and diagnosis applications is also contributing to the growth of this market. However, factors such as stringent regulatory norms and limited number of suppliers are restraining the growth of this market. On the basis of type, stable isotopes accounted for majority share in 2017 and is expected to maintain its dominance during forecast period. This can be attributed to their wide range of applications across various end-use industries. Radioisotopes are projected to grow at a higher CAGR owing to their growing demand in nuclear therapy application segment. On the basis on application, nuclear therapy held major share in 2017 and is anticipated witness highest CAGR during forecast period owing rising incidence cancer patients globally coupled with technological advancements made in radiotherapy treatments segments . Equipment radioactive source segment accounted second largest share followed by diagnosis application segments respectively .
Product Definition:
A medical isotope is a radioactive form of an element that is used in medicine to diagnose and treat diseases. Isotopes emit radiation that can be seen by imaging devices such as x-rays, CT scans, and MRI machines. They can also be used to treat cancers with radiation therapy.
Stable Isotopes:
Stable isotopes are the ones that have a very long half-life and can be used for medical procedures without any complications. The most commonly used stable isotopes are hydrogen, carbon, nitrogen and oxygen. Isotopes are elements which have the same atomic number but different mass numbers (e.g., Carbon has 6 protons and 8 electrons - it is an isotope of element carbon).
Radioisotopes:
Radioisotopes are the radioactive substances that can be produced from unstable elements. The most common radioactive element used in medical isotopes is carbon with a half-life of 5.27 billion years. Other radioactive elements having short half-lives include uranium (uranium-233, which has a life of only 2.6 days), potassium (which has a life of 1 second), and sodium (which has a life of 3 seconds).
Application Insights:
Medical isotopes play a significant role in the diagnosis of diseases. The most commonly used medical isotopes are radioisotopes, which are used for imaging and therapy purposes. Some of the commonly used medical radioisotopes include Technetium (Tc-99m), Iodine (I-131), and Strontium (Sr-89).
The nuclear medicine segment dominated the global market with a revenue share of over 25% in 2017 owing to its high application rate across various diagnostic modalities such as cardiology, neurology, endocrinology, bone metastasis imaging etc. Moreover, increasing R&D activities pertaining to new applications is expected to drive growth during the forecast period thereby contributing towards overall market growth by 2030.
Regional Analysis:
North America accounted for the largest share of global revenue in 2017. The region is expected to maintain its dominance over the forecast period owing to high R&D investments and increasing healthcare spending by governments. In addition, growing number of nuclear reactors in U.S., which require radioactive isotopes for medical purposes, is anticipated to drive regional market growth during the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions during the same period owing to rising demand from developing countries such as China and India due to rapid economic development and increasing population along with rising awareness about nuclear treatment & diagnosis in these nations.
Growth Factors:
- Increasing demand for medical isotopes from the emerging economies due to the rising incidence of cancer and other diseases.
- Proliferation of nuclear reactors across the globe, especially in Asia Pacific, which is expected to drive the growth of medical isotopes market over the forecast period.
- Growing number of private and government-funded research initiatives for development of new applications for medical isotopes is anticipated to boost market growth during forecast period.
- Rising demand for positron emission tomography (PET) scans owing to increasing prevalence of chronic diseases such as cancer and Alzheimer’s disease is projected to fuel market growth in near future
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Isotopes Market Research Report
By Type
Stable Isotopes, Radioisotopes
By Application
Nuclear Therapy, Equipment Radioactive Source, Diagnosis
By Companies
NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories, Eckert & Ziegler Strahlen, Polatom, Center of Molecular Research, China National Nuclear Corporation, Urenco, LANL, Shanghai Engineering Research Center, IDB Holland, NHTC, Linde, ORNL, SI Science
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Medical Isotopes Market Report Segments:
The global Medical Isotopes market is segmented on the basis of:
Types
Stable Isotopes, Radioisotopes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nuclear Therapy, Equipment Radioactive Source, Diagnosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- IRE
- Nordion
- Curium Pharma
- Cambridge Isotope Laboratories
- Eckert & Ziegler Strahlen
- Polatom
- Center of Molecular Research
- China National Nuclear Corporation
- Urenco
- LANL
- Shanghai Engineering Research Center
- IDB Holland
- NHTC
- Linde
- ORNL
- SI Science
Highlights of The Medical Isotopes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stable Isotopes
- Radioisotopes
- By Application:
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Isotopes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical isotopes are atoms that have been enriched in one or more nuclear elements. This enrichment makes the atom more radioactive and allows it to be used in medical procedures to help diagnose and treat diseases.
Some of the major companies in the medical isotopes market are NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories, Eckert & Ziegler Strahlen, Polatom, Center of Molecular Research, China National Nuclear Corporation, Urenco, LANL, Shanghai Engineering Research Center, IDB Holland, NHTC, Linde, ORNL, SI Science.
The medical isotopes market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Isotopes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Isotopes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Isotopes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Isotopes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Isotopes Market Size & Forecast, 2020-2028
4.5.1 Medical Isotopes Market Size and Y-o-Y Growth
4.5.2 Medical Isotopes Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Stable Isotopes
5.2.2 Radioisotopes
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Nuclear Therapy
6.2.2 Equipment Radioactive Source
6.2.3 Diagnosis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Isotopes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Isotopes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Stable Isotopes
9.6.2 Radioisotopes
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Nuclear Therapy
9.10.2 Equipment Radioactive Source
9.10.3 Diagnosis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Stable Isotopes
10.6.2 Radioisotopes
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Nuclear Therapy
10.10.2 Equipment Radioactive Source
10.10.3 Diagnosis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Stable Isotopes
11.6.2 Radioisotopes
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Nuclear Therapy
11.10.2 Equipment Radioactive Source
11.10.3 Diagnosis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Stable Isotopes
12.6.2 Radioisotopes
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Nuclear Therapy
12.10.2 Equipment Radioactive Source
12.10.3 Diagnosis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Stable Isotopes
13.6.2 Radioisotopes
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Nuclear Therapy
13.10.2 Equipment Radioactive Source
13.10.3 Diagnosis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Isotopes Market: Competitive Dashboard
14.2 Global Medical Isotopes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 NRG
14.3.2 NTP Radioisotopes
14.3.3 JSC Isotope
14.3.4 ANSTO
14.3.5 IRE
14.3.6 Nordion
14.3.7 Curium Pharma
14.3.8 Cambridge Isotope Laboratories
14.3.9 Eckert & Ziegler Strahlen
14.3.10 Polatom
14.3.11 Center of Molecular Research
14.3.12 China National Nuclear Corporation
14.3.13 Urenco
14.3.14 LANL
14.3.15 Shanghai Engineering Research Center
14.3.16 IDB Holland
14.3.17 NHTC
14.3.18 Linde
14.3.19 ORNL
14.3.20 SI Science
